← All trials
NCT05751720
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2023
- Primary completion
- Sep 30, 2024
- Completion date
- Feb 28, 2025
- First posted
- Mar 2, 2023
- Last posted
- Mar 2, 2023
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- United Arab Emirates UniversityLead sponsor
- United Arab Emirates UniversitySponsor investigator
- United Arab Emirates UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.